Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults

Nachum Vaisman, Gideon Koren, Dan Goldstein, Gerard J. Canny, Y. K. Tan, Steven Soldin, Paul Pencharz

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

We studied the disposition of inhaled salbutamol in adolescents with cysticfibrosis (CF) and compared it with the pharmacokinetics of the drug given by the intravenous and inhaled routes in healthy adults. After inhalation of salbutamol, CF patients had a significantly larger area under the concentration-time curve derived from amounts of drug in the systemic circulation. The differences in serum concentration of salbutamol were not reflected, in differences in change of heart rate. We conclude that the rate and extent of pulmonary absorption of inhaled salbutamol in patients with CF differ from those in healthy adults.

Original languageEnglish
Pages (from-to)914-917
Number of pages4
JournalJournal of Pediatrics
Volume111
Issue number6 PART 1
DOIs
StatePublished - Dec 1987
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults'. Together they form a unique fingerprint.

Cite this